# Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

> **NCT00106964** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 371 (actual)

## Conditions studied

- HIV Infection
- Hepatitis B

## Interventions

- **BIOLOGICAL:** Engerix-B 20 mcg
- **BIOLOGICAL:** Engerix-B 40 mcg
- **BIOLOGICAL:** Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg

## Key facts

- **NCT ID:** NCT00106964
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2008-01
- **Final completion:** 2009-06
- **Target enrollment:** 371 (ACTUAL)
- **Last updated:** 2017-03-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00106964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00106964, "Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00106964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*